Taken together, our current study demonstrated that the peripheral CB1R antagonist LH-21 is effective in ameliorating obesity-accompanied high blood pressure in the KKAy mice model of obesity and diabetes, and concomitantly improves systemic glucose handling and dyslipidemia. This evidence concerns the gene CNR1 and hypertensive disorder.